We are de-risking biomedical innovation, turning biomedical knowledge into social and economic value.
More than three decades later, we remain committed in pursuit of pharmaceutical innovation, providing high quality products and striving to deliver superior business results.
The patient is at the heart of what we do, making decisions regarding biometric innovation is usually a complicated and chaotic procedure as it consists of various product options, various facets to ascertain these on, and multiple evaluations at all levels.
Discover our therapeutic areas, where we continuously invest to innovate and deliver therapeutic solutions for patient’s benefit.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
14
Aug 2026
A new clinical study shows that AstaReal’s natural astaxanthin significantly improves cognitive performance and resilience to mental fatigue in recreationally active young women.
14
Aug 2026
Most people in the UK already monitor their own health and wellbeing, and an overwhelming majority would be happy to do more if advised by the NHS, according to a new University of Manchester led study.
14
Aug 2026
The Shelford Group has announced a major expansion of its pioneering Surgical Training in Advanced Robotic Technology (START) program, extending accredited, platform-agnostic robotic surgery training to surgical trainees across the South East of England.
14
Aug 2026
In a 30-year study of 973 middle-aged Swedish male automotive workers, alcohol consumption was associated with lower all-cause mortality and longer estimated time to death, while beer consumption was linked to a higher likelihood of myocardial infarction. No significant association was found between alcohol consumption and stroke, and the authors cautioned that socioeconomic differences, self-reported intake, and other unmeasured factors may have influenced the findings.